Results 31 to 40 of about 22,128 (232)

Dendritic Cell Density and Morphology Can Be Used to Differentiate Vernal Keratoconjunctivitis from Allergic Conjunctivitis. [PDF]

open access: yesBiomolecules, 2023
The aim of the study was to compare the distribution of corneal and conjunctival epithelial dendritic cells (DCs) in vernal keratoconjunctivitis (VKC), allergic conjunctivitis (AC), and non-allergic controls to examine if the allergy type causes ...
Tajbakhsh Z   +7 more
europepmc   +2 more sources

Tear ferning test and pathological effects on ocular surface before and after topical cyclosporine in vernal keratoconjunctivitis patients [PDF]

open access: yes, 2018
Background: Vernal keratoconjunctivitis (VKC) is a rare ocular surface inflammatory disease that affects mainly boys in the first decade of life.
Bianchi, Guia   +6 more
core   +1 more source

Sex hormones in allergic conjunctivitis: altered levels of circulating androgens and estrogens in children and adolescents with vernal keratoconjunctivitis [PDF]

open access: yes, 2015
PURPOSE: Vernal keratoconjunctivitis (VKC) is a chronic allergic disease mainly affecting boys in prepubertal age and usually recovering after puberty.
Bonini, S.   +4 more
core   +4 more sources

Surgical Treatment of Corneal Shield Ulcer in Vernal Keratoconjunctivitis: A Systematic Review. [PDF]

open access: yesJ Pers Med, 2023
Background: Vernal keratoconjunctivitis (VKC) severely affects the quality of life of affected patients. The development of a shield ulcer is considered one of the most severe late-stage complications, which when untreated leads to irreversible vision ...
Azizi S, Subhi Y, Rasmussen MLR.
europepmc   +2 more sources

Vascular endothelial growth factor (VEGF) serological and lacrimal signaling in patients affected by vernal keratoconjunctivitis (VKC) [PDF]

open access: yes, 2018
Background. Vernal keratoconjunctivitis (VKC) is a rare inflammatory disease involving the ocular surface, with seasonally exacerbated symptoms. Both type-1 and type-4 hypersensitivity reactions play a role in the development of VKC. Purpose.
Aventaggiato, Michele   +5 more
core   +1 more source

Electro‐compacted collagen for corneal epithelial tissue engineering

open access: yesJournal of Biomedical Materials Research Part A, Volume 111, Issue 8, Page 1151-1160, August 2023., 2023
Abstract Bioengineered corneal substitutes offer a solution to the shortage of donor corneal tissue worldwide. As one of the major structural components of the cornea, collagen has shown great potential for tissue‐engineered cornea substitutes. Herein, free‐standing collagen membranes fabricated using electro‐compaction were assessed in corneal ...
Zhi Chen   +8 more
wiley   +1 more source

An observational study on the presence of perilimbal conjunctival pigmentation in vernal keratoconjunctivitis. [PDF]

open access: yesIndian J Ophthalmol, 2023
Purpose: To evaluate presence of perilimbal pigmentation (PLP) in Indian patients with vernal keratoconjunctivitis (VKC). Methods: A cross sectional study was conducted from 2019 to 2020 at a tertiary eye care center in Western Maharashtra, India.
Dubbaka S   +4 more
europepmc   +2 more sources

Clinical Study on Corneal Topographical Changes in Vernal Keratoconjunctivitis by Using OCULUS Pentacam®. [PDF]

open access: yesCureus, 2023
Purpose: To evaluate the corneal topographical changes in vernal keratoconjunctivitis (VKC) subjects using OCULUS Pentacam. Design: This was a cross-sectional study.
Thiagarajan D   +3 more
europepmc   +2 more sources

Japanese guidelines for allergic conjunctival diseases 2020

open access: yesAllergology International, 2020
The definition, classification, pathogenesis, test methods, clinical findings, criteria for diagnosis, and therapies of allergic conjunctival disease are summarized based on the Guidelines for Clinical Management of Allergic Conjunctival Disease 2019 ...
Dai Miyazaki   +12 more
doaj   +1 more source

Biologics for allergy: therapeutic potential for ocular allergic diseases and adverse effects on the eye

open access: yesAllergology International, 2023
Biologics applying antibodies against IgE, IL-5, IL-5 receptor α, IL-4 receptor α, and IL-13 have dramatically improved recent treatment outcomes in allergic diseases including asthma, rhinitis, and atopic dermatitis.
Ken Fukuda   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy